Labrepco LLC

Labrepco LLC operates as a small business prime contractor supplying laboratory equipment and scientific instrumentation to federal agencies, with specialization in ultra-low temperature freezers, biosafety cabinets, CO2 incubators, refrigeration systems, and cryogenic storage—products sourced from OEM manufacturers and resold through federal contract vehicles. The company competes predominantly in full-and-open procurements, with total-small-business set-asides appearing in roughly 15–20% of recent awards; the bulk of volume flows through unrestricted delivery orders.

Labrepco's customer concentration reflects the Defense Logistics Agency's Medical Supply Chain program dominance. The DLA Troop Support Medical accounts for 955 awards worth $1.05 billion in combined potential value, representing roughly 87% of the company's total award dollar volume and nearly 36% of award count. The National Institutes of Health Office of Logistics and Acquisition Operations holds a $100 million single-award Blanket Purchase Agreement, the company's flagship vehicle, which anchors NIH work and supports subordinate institutes and cross-agency use. CDC Pittsburgh (60 awards, $2.4 million), FDA (64 awards, $1.3 million), Navy Bureau of Medicine and Surgery (115 awards, $1.8 million), and the National Institutes of Allergy and Infectious Diseases (62 awards, $1.8 million) round out the active federal customer base, collectively covering 47% of award count. The split between top customers by volume and by dollar value is stark: the DLA dominates dollars; NIH's $100 million BPA and the $15.3 million MAS pool distribute dollars across 392 task orders at lower individual values.

Vehicle-wise, Labrepco holds positions on the General Services Administration Federal Supply Schedule GS24F9018H (790 task orders, $7.6 million potential value), the GSA Multiple Award Schedule (392 task orders, $15.3 million), and several DLA indefinite-delivery contracts—SPE2DH22D0014 (455 task orders, $7 million), SPE2DH17D0017 (351 task orders, $4.1 million), and SPM2DH12D8214 (113 task orders, $3.8 million). These vehicles are call-order mechanisms; the real ceiling sits in the $100 million NIH BPA and the effectively unlimited DLA Medical Supply Chain relationship. Task-order count far exceeds prime contract count, indicating Labrepco operates almost exclusively as a catalog vendor responding to spot purchases rather than as a program integrator.

Activity has held relatively flat over the past five years—146 to 188 awards annually from 2022 to 2024, dropping to 120 so far in 2026—suggesting mature, stable demand rather than growth. Combined potential value stands at $1.21 billion against only $46.4 million in actual obligations (4% draw-down), reflecting the long tail of option periods and indefinite-quantity ceilings. Recompete exposure in the next twenty-four months is modest: 14 awards totaling $587 thousand in ceiling value face completion, a negligible share of the portfolio.

Labrepco's award distribution by product class is consistent with its reseller posture. Medical, Dental, and Hospital Equipment merchant wholesaler NAICS (935 awards) and Instrument Manufacturing for Electrical Measurement (792 awards) lead; Air-Conditioning and Refrigeration Equipment Manufacturing (449 awards) and Analytical Laboratory Instrument Manufacturing (166 awards) reflect the mix. By PSC, Hospital Furniture, Equipment, Utensils, and Supplies (943 awards) and Laboratory Equipment and Supplies (903 awards) are the clear leaders, with Refrigeration Equipment (290 awards) and Medical and Surgical Instruments (272 awards) following. This pattern—high-count, low-value task orders for consumable and standard OEM equipment—is textbook government supply-catalog work.

Labrepco carries one significant subcontract engagement: a modification to a Caci Technologies contract dated August 2024 for computer equipment and system modifications, valued in the low six figures. This represents incidental work outside the company's primary distribution focus and is not a strategic teaming relationship.

The company's federal footprint is heavily defense-anchored through DLA and health-services-anchored through NIH and interagency research use. Labrepco functions as a specialized logistics node, procuring manufactured equipment from multiple OEMs and distributing it on call against pre-negotiated pricing and delivery terms. Capacity constraints are unlikely; recompete risk is negligible; and pipeline dynamics favor order volume rather than contract complexity or innovation.

LABREPCO sells laboratory equipment for the research lab market which includes clinical, pharmaceutical, forensic and goverment accounts among others. We also specialize in the sale of lab equipment for new construction and rennovations.